(courtesy NORML Foundation, http://www.norml.org)
Ottawa, Ontario: An English pharmaceutical
company specializing in medicinal cannabis extracts has received permission
to study the effects of a marijuana spray on chronic pain patients in Canada.
The upcoming randomized, double-blind study will be the first trial of
its kind in Canada.
"The start of clinical trials in Canada
is the first phase of our international trials program," said Dr. Geoffrey
Guy, chairman of GW Pharmaceuticals in London. "The Canadian health
authorities have recognized the potential contribution of cannabis-based
medicines in the treatment of many different conditions."
Patients suffering from Multiple Sclerosis,
spinal cord injury and other forms of chronic pain will participate in
the study, which will be performed at The Rehabilitation Centre in
Results of a previous UK trial of 75 patients
found that marijuana extracts administered under the tongue greatly reduced
pain, muscle spasms and bladder dysfunction in patients with MS.
Since June, Health Canada has appropriated
more than a million dollars to fund medicinal cannabis research, including
an $840,000 grant to study the efficacy of smoked marijuana in the treatment
of the AIDS wasting syndrome.
-- END --
Issue #199, 8/17/01
Editorial: Let Justice Be Done | US Global Lead in Imprisonment Still Safe: State Prison Populations Begin to Decline but Feds Make Up Difference | Prison Industry Confab Gets Heated Reception in Philadelphia | Mandatory Minimums Under Threat, Supreme Court Showdown Looming After 9th Circuit Rules Against Certain Drug Sentencing Laws | Oregon Bar Ethics Brouhaha Continues: Feds Still Refusing to Authorize Undercover Operations, State Narcs Could Be Out There | Department of Education Cites Pressure to Modify Restrictions on Financial Aid | Australia: Top Cops Propose "Heroin Bank," Political Firestorm Ensues as Prime Minister Nixes Idea | Chess Players Become Drug Tested Pawns in Game's Bid for Olympic Status, Players Not Amused | Vermont Governor Leads Way in Restricting Oxycontin for the Poor | Weitzel Prosecution Condemned by Leading Pain Specialist | Marijuana Extracts for Pain Study to Begin in Canada | DRCNet Book Review: Hooked: Five Addicts Challenge Our Misguided Drug Rehab System | T-shirts for Victory! Special Offer and Appeal from DRCNet This Month | Action Alerts: Ecstasy Bill, HEA, Mandatory Minimums, Medical Marijuana, John Walters | HEA Campaign Still Seeking Student Victim Cases -- New York Metropolitan Area Especially Urgent | The Reformer's Calendar
Mail this article to a friend
Send us feedback on this article
This issue -- main page
This issue -- single-file printer version
Drug War Chronicle -- main page
PERMISSION to reprint or
redistribute any or all of the contents of Drug War Chronicle (formerly The Week Online with DRCNet is hereby
granted. We ask that any use of these materials include proper credit and,
where appropriate, a link to one or more of our web sites. If your
publication customarily pays for publication, DRCNet requests checks
payable to the organization. If your publication does not pay for
materials, you are free to use the materials gratis. In all cases, we
request notification for our records, including physical copies where
material has appeared in print. Contact: StoptheDrugWar.org: the Drug Reform Coordination Network,
P.O. Box 18402, Washington, DC 20036, (202) 293-8340 (voice), (202)
293-8344 (fax), e-mail [email protected]. Thank
Articles of a purely
educational nature in Drug War Chronicle appear courtesy of the DRCNet
Foundation, unless otherwise noted.